25 September 2014 - Deborah Wilkes
Archived
The European Union's regulatory system for medicines could be used in a "more efficient and effective manner", according to research carried out by Escher, which identifies problems with pharmacovigilance as well as the mutual recognition and decentralised authorisation procedures.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.